Karthik Lingineni, PhD

Sr. Principal Pharmacometrician
Novartis Pharmaceutical Corporation

Poster(s):

• (M-106) An Integrated model of Lu-PSMA-617 dose, tumor dosimetry, PSA and OS to enable future study design
  Monday, October 20, 2025

  7:00 AM - 5:00 PM MDT